The multifunctional enzyme PARP plays an important role in DNA damage repair and genome stability, and in preclinical and clinical studies, PARP inhibitors have been found to restrain DNA repair pathways and induce the apoptosis of cancer cells with deficiencies in HR-mediated DNA repair, such as those carrying BRCA mutations [3]. Here, PARP1 is linked to cancer.